| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA cap binding | 2.22e-05 | 4 | 39 | 2 | GO:0098808 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 1.34e-04 | 51 | 39 | 3 | GO:0003743 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 3.33e-04 | 14 | 39 | 2 | GO:0000340 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 6.09e-04 | 85 | 39 | 3 | GO:0008135 | |
| GeneOntologyMolecularFunction | RNA cap binding | 7.62e-04 | 21 | 39 | 2 | GO:0000339 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 1.36e-03 | 112 | 39 | 3 | GO:0090079 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 1.56e-03 | 30 | 39 | 2 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 1.56e-03 | 30 | 39 | 2 | GO:0097472 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 2.63e-03 | 39 | 39 | 2 | GO:0031369 | |
| GeneOntologyMolecularFunction | cadherin binding | 4.20e-03 | 339 | 39 | 4 | GO:0045296 | |
| Domain | TIF_eIF_4E_CS | 1.27e-05 | 3 | 39 | 2 | IPR019770 | |
| Domain | IF4E | 2.54e-05 | 4 | 39 | 2 | PS00813 | |
| Domain | IF4E | 2.54e-05 | 4 | 39 | 2 | PF01652 | |
| Domain | - | 4.23e-05 | 5 | 39 | 2 | 3.30.760.10 | |
| Domain | TIF_eIF_4E | 4.23e-05 | 5 | 39 | 2 | IPR001040 | |
| Domain | TIF_eIF4e-like | 4.23e-05 | 5 | 39 | 2 | IPR023398 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | CKAP5 SERBP1 DDX46 RPS2 PUF60 CALU AMOT CANX ESF1 EIF4E EIF3CL | 3.50e-08 | 1149 | 39 | 11 | 35446349 |
| Pubmed | 7.52e-08 | 503 | 39 | 8 | 16964243 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.26e-07 | 759 | 39 | 9 | 35915203 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.12e-07 | 807 | 39 | 9 | 22681889 | |
| Pubmed | 2.39e-07 | 390 | 39 | 7 | 17643375 | ||
| Pubmed | 4.42e-07 | 55 | 39 | 4 | 27114453 | ||
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 4.56e-07 | 137 | 39 | 5 | 37039823 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 4.63e-07 | 639 | 39 | 8 | 23443559 | |
| Pubmed | 5.45e-07 | 653 | 39 | 8 | 22586326 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 1.18e-06 | 495 | 39 | 7 | 28581483 | |
| Pubmed | Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. | 1.23e-06 | 2 | 39 | 2 | 8195233 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7920654 | ||
| Pubmed | Regulated expression of a cell division control-related protein kinase during development. | 1.23e-06 | 2 | 39 | 2 | 2069872 | |
| Pubmed | A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand. | 1.23e-06 | 2 | 39 | 2 | 7528743 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 1774066 | ||
| Pubmed | CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization. | 1.23e-06 | 2 | 39 | 2 | 28101846 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 30722725 | ||
| Pubmed | Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. | 1.23e-06 | 2 | 39 | 2 | 10882096 | |
| Pubmed | The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. | 1.23e-06 | 2 | 39 | 2 | 27049727 | |
| Pubmed | Structure and expression of the human p58clk-1 protein kinase chromosomal gene. | 1.23e-06 | 2 | 39 | 2 | 1639388 | |
| Pubmed | Protein expression pattern of CDK11(p58) during testicular development in the mouse. | 1.23e-06 | 2 | 39 | 2 | 15792358 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15060143 | ||
| Pubmed | 1.36e-06 | 506 | 39 | 7 | 30890647 | ||
| Pubmed | 1.91e-06 | 335 | 39 | 6 | 15741177 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CKAP5 AKAP13 SERBP1 DDX46 RPS2 PUF60 CANX SYNE2 EIF4E EIF4E2 | 2.60e-06 | 1415 | 39 | 10 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 2.77e-06 | 1425 | 39 | 10 | 30948266 | |
| Pubmed | CKAP5 SLC4A10 IL12RB1 SERBP1 RPS2 AMOT PDHX EIF4E EIF3CL EHD3 | 2.88e-06 | 1431 | 39 | 10 | 37142655 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 19122208 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 9580558 | ||
| Pubmed | The RBBP6/ZBTB38/MCM10 axis regulates DNA replication and common fragile site stability. | 3.67e-06 | 3 | 39 | 2 | 24726359 | |
| Pubmed | Characterizing the interaction of the mammalian eIF4E-related protein 4EHP with 4E-BP1. | 3.67e-06 | 3 | 39 | 2 | 15094042 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 23991149 | ||
| Pubmed | The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM. | 3.67e-06 | 3 | 39 | 2 | 14511641 | |
| Pubmed | Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice. | 3.67e-06 | 3 | 39 | 2 | 17389615 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 12624090 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 33664748 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 28942592 | ||
| Pubmed | Distinct recruitment of human eIF4E isoforms to processing bodies and stress granules. | 3.67e-06 | 3 | 39 | 2 | 27578149 | |
| Pubmed | Cap-binding protein 4EHP effects translation silencing by microRNAs. | 3.67e-06 | 3 | 39 | 2 | 28487484 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 4.11e-06 | 1155 | 39 | 9 | 20360068 | |
| Pubmed | 4.23e-06 | 601 | 39 | 7 | 33658012 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 12501247 | ||
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 24436071 | ||
| Pubmed | A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. | 7.34e-06 | 4 | 39 | 2 | 7777541 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 15330758 | ||
| Pubmed | Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. | 7.34e-06 | 4 | 39 | 2 | 2217177 | |
| Pubmed | A threonyl-tRNA synthetase-mediated translation initiation machinery. | 7.34e-06 | 4 | 39 | 2 | 30902983 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 9750192 | ||
| Pubmed | Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. | 7.34e-06 | 4 | 39 | 2 | 17698582 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 9115219 | ||
| Pubmed | 7.89e-06 | 245 | 39 | 5 | 19521500 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 8.67e-06 | 949 | 39 | 8 | 36574265 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 9.75e-06 | 256 | 39 | 5 | 24189400 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 17516030 | ||
| Pubmed | Riz maps to distal chromosome 4 near genes involved in tumorigenesis and nerve degeneration. | 1.22e-05 | 5 | 39 | 2 | 8679000 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 24365888 | ||
| Pubmed | The gene for mouse p58cdc2L1 (Cdc2l1) protein kinase maps to distal mouse chromosome 4. | 1.22e-05 | 5 | 39 | 2 | 8199413 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 9632733 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 16963292 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 1.29e-05 | 468 | 39 | 6 | 36042349 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.42e-05 | 724 | 39 | 7 | 36232890 | |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 1.49e-05 | 480 | 39 | 6 | 25437307 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.50e-05 | 1024 | 39 | 8 | 24711643 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.59e-05 | 1367 | 39 | 9 | 32687490 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 1.59e-05 | 486 | 39 | 6 | 30940648 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 32268115 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 28698298 | ||
| Pubmed | Tracking a refined eIF4E-binding motif reveals Angel1 as a new partner of eIF4E. | 1.83e-05 | 6 | 39 | 2 | 23814182 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 15963510 | ||
| Pubmed | An oxygen-regulated switch in the protein synthesis machinery. | 1.83e-05 | 6 | 39 | 2 | 22678294 | |
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 19245811 | ||
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 2.56e-05 | 7 | 39 | 2 | 15883043 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 15153109 | ||
| Pubmed | A novel 4EHP-GIGYF2 translational repressor complex is essential for mammalian development. | 2.56e-05 | 7 | 39 | 2 | 22751931 | |
| Pubmed | 2.89e-05 | 809 | 39 | 7 | 32129710 | ||
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 3.28e-05 | 55 | 39 | 3 | 23178491 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 3.37e-05 | 163 | 39 | 4 | 22113938 | |
| Pubmed | Genomic organization and genetic mapping of the neuroimmune gene I2rf5 to mouse chromosome 4. | 3.42e-05 | 8 | 39 | 2 | 7774930 | |
| Pubmed | FBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrest. | 3.42e-05 | 8 | 39 | 2 | 22024926 | |
| Pubmed | 3.51e-05 | 1153 | 39 | 8 | 29845934 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.29e-05 | 861 | 39 | 7 | 36931259 | |
| Pubmed | The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors. | 4.36e-05 | 350 | 39 | 5 | 26549023 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 14623875 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.41e-05 | 605 | 39 | 6 | 28977666 | |
| Pubmed | 5.43e-05 | 65 | 39 | 3 | 22379092 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 6.04e-05 | 375 | 39 | 5 | 32788342 | |
| Pubmed | 7.03e-05 | 197 | 39 | 4 | 32434143 | ||
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 7.90e-05 | 203 | 39 | 4 | 24244333 | |
| Pubmed | 8.03e-05 | 12 | 39 | 2 | 19884882 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 9.11e-05 | 665 | 39 | 6 | 30457570 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 9.13e-05 | 1321 | 39 | 8 | 27173435 | |
| Pubmed | 9.82e-05 | 1335 | 39 | 8 | 29229926 | ||
| Pubmed | 1.01e-04 | 418 | 39 | 5 | 35338135 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.05e-04 | 422 | 39 | 5 | 27342126 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 1.08e-04 | 220 | 39 | 4 | 34091597 | |
| Pubmed | 1.14e-04 | 1007 | 39 | 7 | 34597346 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.22e-04 | 701 | 39 | 6 | 30196744 | |
| Pubmed | Kinome siRNA screen identifies regulators of ciliogenesis and hedgehog signal transduction. | 1.27e-04 | 15 | 39 | 2 | 18827223 | |
| Pubmed | 1.31e-04 | 711 | 39 | 6 | 33022573 | ||
| Pubmed | 1.44e-04 | 723 | 39 | 6 | 34133714 | ||
| Interaction | EIF3H interactions | 5.62e-08 | 282 | 39 | 8 | int:EIF3H | |
| Interaction | EIF3F interactions | 8.17e-08 | 296 | 39 | 8 | int:EIF3F | |
| Interaction | EIF3G interactions | 4.44e-07 | 249 | 39 | 7 | int:EIF3G | |
| Interaction | EIF3I interactions | 5.63e-07 | 258 | 39 | 7 | int:EIF3I | |
| Interaction | ACTC1 interactions | 5.66e-07 | 694 | 39 | 10 | int:ACTC1 | |
| Interaction | NOP56 interactions | 1.08e-06 | 570 | 39 | 9 | int:NOP56 | |
| Interaction | DTYMK interactions | 1.54e-06 | 44 | 39 | 4 | int:DTYMK | |
| Interaction | CIT interactions | CKAP5 SLC4A10 CDK11A EED SERBP1 DDX46 RPS2 PUF60 CALU CANX ESF1 SYNE2 EIF3CL | 1.81e-06 | 1450 | 39 | 13 | int:CIT |
| Interaction | EIF3B interactions | 3.34e-06 | 337 | 39 | 7 | int:EIF3B | |
| Interaction | DYNLL1 interactions | 4.91e-06 | 510 | 39 | 8 | int:DYNLL1 | |
| Interaction | RPS24 interactions | 6.42e-06 | 529 | 39 | 8 | int:RPS24 | |
| Interaction | EIF3L interactions | 6.92e-06 | 244 | 39 | 6 | int:EIF3L | |
| Interaction | SNRPD3 interactions | 7.33e-06 | 380 | 39 | 7 | int:SNRPD3 | |
| Interaction | SIRT1 interactions | 1.24e-05 | 412 | 39 | 7 | int:SIRT1 | |
| Interaction | HECTD1 interactions | 1.28e-05 | 984 | 39 | 10 | int:HECTD1 | |
| Interaction | PDLIM5 interactions | 1.31e-05 | 273 | 39 | 6 | int:PDLIM5 | |
| Interaction | QSOX2 interactions | 1.62e-05 | 79 | 39 | 4 | int:QSOX2 | |
| Interaction | YWHAG interactions | CKAP5 AKAP13 EED SERBP1 CDK11B PIK3C3 RPS2 PUF60 AMOT SYNE2 EIF4E2 | 1.65e-05 | 1248 | 39 | 11 | int:YWHAG |
| Interaction | RPS5 interactions | 1.66e-05 | 431 | 39 | 7 | int:RPS5 | |
| Interaction | METAP2 interactions | 1.81e-05 | 289 | 39 | 6 | int:METAP2 | |
| Interaction | USP4 interactions | 1.96e-05 | 293 | 39 | 6 | int:USP4 | |
| Interaction | PLOD2 interactions | 2.42e-05 | 180 | 39 | 5 | int:PLOD2 | |
| Interaction | CDK11B interactions | 2.62e-05 | 183 | 39 | 5 | int:CDK11B | |
| Interaction | BAP1 interactions | CKAP5 SERBP1 DDX46 RPS2 PUF60 CALU AMOT CANX ESF1 EIF4E EIF3CL | 2.66e-05 | 1314 | 39 | 11 | int:BAP1 |
| Interaction | UBE2M interactions | 2.88e-05 | 651 | 39 | 8 | int:UBE2M | |
| Interaction | EZH1 interactions | 2.96e-05 | 92 | 39 | 4 | int:EZH1 | |
| Interaction | RNF2 interactions | 3.17e-05 | 866 | 39 | 9 | int:RNF2 | |
| Interaction | EIF3CL interactions | 3.79e-05 | 98 | 39 | 4 | int:EIF3CL | |
| Interaction | UHRF2 interactions | 4.01e-05 | 200 | 39 | 5 | int:UHRF2 | |
| Interaction | DDX18 interactions | 4.08e-05 | 334 | 39 | 6 | int:DDX18 | |
| Interaction | PCGF5 interactions | 4.27e-05 | 101 | 39 | 4 | int:PCGF5 | |
| Interaction | CLPTM1L interactions | 4.27e-05 | 101 | 39 | 4 | int:CLPTM1L | |
| Interaction | JMJD6 interactions | 4.51e-05 | 205 | 39 | 5 | int:JMJD6 | |
| Interaction | ATG13 interactions | 4.83e-05 | 208 | 39 | 5 | int:ATG13 | |
| Interaction | XRCC6 interactions | 5.45e-05 | 928 | 39 | 9 | int:XRCC6 | |
| Interaction | NUCKS1 interactions | 6.30e-05 | 220 | 39 | 5 | int:NUCKS1 | |
| Interaction | EFTUD2 interactions | CKAP5 PAN2 AKAP13 EED SERBP1 RPS2 PUF60 CANX SYNE2 EIF4E EIF4E2 | 6.54e-05 | 1449 | 39 | 11 | int:EFTUD2 |
| Interaction | CSNK2A1 interactions | 6.85e-05 | 956 | 39 | 9 | int:CSNK2A1 | |
| Interaction | B3GNT2 interactions | 7.13e-05 | 542 | 39 | 7 | int:B3GNT2 | |
| Interaction | SIRT7 interactions | 7.40e-05 | 744 | 39 | 8 | int:SIRT7 | |
| Interaction | METTL14 interactions | 8.56e-05 | 558 | 39 | 7 | int:METTL14 | |
| Interaction | GNL2 interactions | 9.08e-05 | 386 | 39 | 6 | int:GNL2 | |
| Interaction | DDRGK1 interactions | 9.80e-05 | 1249 | 39 | 10 | int:DDRGK1 | |
| Interaction | BTRC interactions | 9.84e-05 | 775 | 39 | 8 | int:BTRC | |
| Interaction | EIF3D interactions | 1.03e-04 | 244 | 39 | 5 | int:EIF3D | |
| Interaction | ANAPC15 interactions | 1.07e-04 | 128 | 39 | 4 | int:ANAPC15 | |
| Interaction | TCEA1 interactions | 1.18e-04 | 131 | 39 | 4 | int:TCEA1 | |
| Interaction | HMGB2 interactions | 1.33e-04 | 258 | 39 | 5 | int:HMGB2 | |
| Interaction | EIF3E interactions | 1.46e-04 | 263 | 39 | 5 | int:EIF3E | |
| Interaction | EIF3C interactions | 1.46e-04 | 263 | 39 | 5 | int:EIF3C | |
| Interaction | UQCR11 interactions | 1.47e-04 | 53 | 39 | 3 | int:UQCR11 | |
| Interaction | RNPS1 interactions | 1.54e-04 | 425 | 39 | 6 | int:RNPS1 | |
| Interaction | ABCC1 interactions | 1.60e-04 | 142 | 39 | 4 | int:ABCC1 | |
| Interaction | EIF4EBP3 interactions | 1.63e-04 | 10 | 39 | 2 | int:EIF4EBP3 | |
| Interaction | CFAP141 interactions | 1.64e-04 | 55 | 39 | 3 | int:CFAP141 | |
| Interaction | RPL27 interactions | 1.66e-04 | 431 | 39 | 6 | int:RPL27 | |
| Interaction | CUL7 interactions | 1.79e-04 | 845 | 39 | 8 | int:CUL7 | |
| Interaction | EIF2D interactions | 1.82e-04 | 57 | 39 | 3 | int:EIF2D | |
| Interaction | SCIN interactions | 1.92e-04 | 58 | 39 | 3 | int:SCIN | |
| Interaction | ARHGAP42 interactions | 2.12e-04 | 60 | 39 | 3 | int:ARHGAP42 | |
| Interaction | KCNA3 interactions | 2.20e-04 | 871 | 39 | 8 | int:KCNA3 | |
| Interaction | PRICKLE2 interactions | 2.34e-04 | 62 | 39 | 3 | int:PRICKLE2 | |
| Interaction | AHSA1 interactions | 2.45e-04 | 294 | 39 | 5 | int:AHSA1 | |
| Interaction | FGD4 interactions | 2.57e-04 | 64 | 39 | 3 | int:FGD4 | |
| Interaction | TTN interactions | 2.65e-04 | 299 | 39 | 5 | int:TTN | |
| Interaction | PCBP1 interactions | 2.67e-04 | 671 | 39 | 7 | int:PCBP1 | |
| Interaction | EIF4ENIF1 interactions | 2.69e-04 | 300 | 39 | 5 | int:EIF4ENIF1 | |
| Interaction | EIF2S3 interactions | 2.90e-04 | 305 | 39 | 5 | int:EIF2S3 | |
| Interaction | GSPT1 interactions | 2.95e-04 | 306 | 39 | 5 | int:GSPT1 | |
| Interaction | INO80B interactions | 2.98e-04 | 167 | 39 | 4 | int:INO80B | |
| Interaction | SERBP1 interactions | 3.01e-04 | 1432 | 39 | 10 | int:SERBP1 | |
| Interaction | STRIP2 interactions | 3.08e-04 | 68 | 39 | 3 | int:STRIP2 | |
| Interaction | MTA3 interactions | 3.41e-04 | 173 | 39 | 4 | int:MTA3 | |
| Interaction | PKM interactions | 3.57e-04 | 497 | 39 | 6 | int:PKM | |
| Interaction | CHD4 interactions | 3.63e-04 | 938 | 39 | 8 | int:CHD4 | |
| Interaction | AKR7L interactions | 3.64e-04 | 72 | 39 | 3 | int:AKR7L | |
| Interaction | RPS12 interactions | 3.67e-04 | 321 | 39 | 5 | int:RPS12 | |
| Interaction | PTPN14 interactions | 3.72e-04 | 177 | 39 | 4 | int:PTPN14 | |
| Interaction | RBM25 interactions | 3.77e-04 | 323 | 39 | 5 | int:RBM25 | |
| Interaction | DDX6 interactions | 3.80e-04 | 503 | 39 | 6 | int:DDX6 | |
| Interaction | RPS11 interactions | 3.88e-04 | 505 | 39 | 6 | int:RPS11 | |
| Interaction | CDK11A interactions | 3.97e-04 | 180 | 39 | 4 | int:CDK11A | |
| Interaction | EIF3M interactions | 4.13e-04 | 182 | 39 | 4 | int:EIF3M | |
| Interaction | TNIP1 interactions | 4.23e-04 | 1217 | 39 | 9 | int:TNIP1 | |
| Interaction | CLTB interactions | 4.40e-04 | 185 | 39 | 4 | int:CLTB | |
| Interaction | RPS26 interactions | 4.40e-04 | 334 | 39 | 5 | int:RPS26 | |
| Interaction | CDKN2A interactions | 4.46e-04 | 335 | 39 | 5 | int:CDKN2A | |
| Interaction | ENY2 interactions | 4.49e-04 | 186 | 39 | 4 | int:ENY2 | |
| Interaction | ACTG1 interactions | 4.54e-04 | 520 | 39 | 6 | int:ACTG1 | |
| Interaction | FERMT2 interactions | 4.77e-04 | 189 | 39 | 4 | int:FERMT2 | |
| Interaction | DDX10 interactions | 4.86e-04 | 190 | 39 | 4 | int:DDX10 | |
| Interaction | RPL15 interactions | 5.02e-04 | 530 | 39 | 6 | int:RPL15 | |
| Interaction | PSENEN interactions | 5.15e-04 | 81 | 39 | 3 | int:PSENEN | |
| Interaction | RPS27 interactions | 5.17e-04 | 346 | 39 | 5 | int:RPS27 | |
| Interaction | SND1 interactions | 5.23e-04 | 347 | 39 | 5 | int:SND1 | |
| Interaction | SF3B6 interactions | 5.26e-04 | 194 | 39 | 4 | int:SF3B6 | |
| Interaction | TARS1 interactions | 5.36e-04 | 195 | 39 | 4 | int:TARS1 | |
| Interaction | MAP1B interactions | 5.48e-04 | 539 | 39 | 6 | int:MAP1B | |
| Interaction | RPS4X interactions | 5.54e-04 | 540 | 39 | 6 | int:RPS4X | |
| Interaction | ITFG1 interactions | 5.54e-04 | 540 | 39 | 6 | int:ITFG1 | |
| Cytoband | 1p36.33 | 1.98e-03 | 77 | 39 | 2 | 1p36.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q32 | 3.11e-03 | 97 | 39 | 2 | chr7q32 | |
| GeneFamily | Cyclin dependent kinases | 5.38e-04 | 26 | 24 | 2 | 496 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 2.74e-06 | 612 | 39 | 8 | M4772 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 1.12e-05 | 199 | 39 | 5 | M3328 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 1.15e-05 | 200 | 39 | 5 | M3020 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 3.14e-05 | 856 | 39 | 8 | M4500 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 6.00e-05 | 685 | 39 | 7 | MM3782 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 9.42e-05 | 311 | 39 | 5 | M40024 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.87e-09 | 192 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.39e-06 | 311 | 39 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.80e-06 | 469 | 39 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CKAP5 ZBTB38 SERBP1 DDX46 CDK11B SLC20A1 CANX ESF1 SYNE2 MAMLD1 | 1.81e-06 | 831 | 39 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CKAP5 EED DDX46 CDK11B MCM10 ZFP69 PODXL SLC20A1 ESF1 SYNE2 MAMLD1 | 2.10e-06 | 1060 | 39 | 11 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 2.81e-06 | 498 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 3.85e-06 | 232 | 39 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CKAP5 DDX46 CDK11B ZFP69 SLC20A1 GPR179 ESF1 SYNE2 EHD3 MAMLD1 | 8.49e-06 | 989 | 39 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CKAP5 SERBP1 DDX46 CDK11B MCM10 SLC20A1 CANX ESF1 SYNE2 MAMLD1 | 8.49e-06 | 989 | 39 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.04e-05 | 595 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CKAP5 EED SERBP1 DDX46 CDK11B MCM10 ZFP69 SLC20A1 CANX ESF1 SYNE2 | 1.08e-05 | 1257 | 39 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.55e-05 | 629 | 39 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.61e-05 | 298 | 39 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.05e-05 | 654 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CKAP5 EED DDX46 CDK11B MCM10 ZFP69 PODXL SLC20A1 ESF1 SYNE2 MAMLD1 | 3.24e-05 | 1414 | 39 | 11 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CKAP5 EED SERBP1 DDX46 CDK11B MCM10 ZFP69 SLC20A1 CANX ESF1 SYNE2 | 4.32e-05 | 1459 | 39 | 11 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CKAP5 DDX46 CDK11B MCM10 ZFP69 PODXL SLC20A1 FBXO30 ESF1 SYNE2 | 6.46e-05 | 1252 | 39 | 10 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.27e-04 | 432 | 39 | 6 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.32e-04 | 271 | 39 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.89e-04 | 156 | 39 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.59e-04 | 493 | 39 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.19e-04 | 328 | 39 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.71e-04 | 339 | 39 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.88e-04 | 532 | 39 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.13e-04 | 203 | 39 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 6.84e-04 | 94 | 39 | 3 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | 6.88e-04 | 1371 | 39 | 9 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.21e-05 | 162 | 39 | 4 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-05 | 166 | 39 | 4 | e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889 | |
| ToppCell | control-Lymphocytic-CD8_T_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.60e-05 | 197 | 39 | 4 | c1c47db5e8d1b248bc192556275edd1ce168a953 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial-RG|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | b3775715b66aee18cff469bf3dbe9c305671c6d6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Radial_glial|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | 9069e8d3bcc5f44baa00f2abb6cffd87586c3eab | |
| ToppCell | (13)_Th17|World / shred on Cell_type and subtype | 2.92e-05 | 203 | 39 | 4 | e8d5db46093160d403ecd51142c3939d522bca8b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-04 | 154 | 39 | 3 | 89c9c9918af32f3952790b41f1471b2c80ffce2f | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_TEM|ICU-NoSEP / Disease, Lineage and Cell Type | 3.54e-04 | 158 | 39 | 3 | 8616b308d5c1a1042b23a9aaca971029ba732eb8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-04 | 158 | 39 | 3 | 5775246e192629058ed89fb56031bdf4cbb9c15c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-04 | 159 | 39 | 3 | 299e2162a82e31196d7f3a110c2db622349edfff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-04 | 159 | 39 | 3 | 0a3a363b30a8c741e1a3e2525725108d03c21776 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.60e-04 | 159 | 39 | 3 | 048b6a97568242c8846034277680632e5de75840 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.88e-04 | 163 | 39 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 164 | 39 | 3 | 1592a5becad7e0f3f990f0d7581d75fcfc7da023 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-04 | 166 | 39 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.09e-04 | 166 | 39 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | severe_influenza-CD4+_CTL|World / disease group, cell group and cell class (v2) | 4.09e-04 | 166 | 39 | 3 | cdc3e200373718f26fe02ee516928097103f46e2 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-04 | 166 | 39 | 3 | 94a00edf66d54bc5f7343daea700ca26cf38fd90 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 167 | 39 | 3 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-04 | 172 | 39 | 3 | 94093d356b0252b440deda4e1b0ac332b31513f6 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 4.69e-04 | 174 | 39 | 3 | 1e289b26e2c29dbad15b712a999b96c391a26129 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-MAIT|Int-URO / Disease, Lineage and Cell Type | 4.69e-04 | 174 | 39 | 3 | 5227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_TEM|IIF / Disease, Lineage and Cell Type | 4.77e-04 | 175 | 39 | 3 | 0e7cde3bd638ab85abe915d40c432123f92af4fc | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.93e-04 | 177 | 39 | 3 | 605f71515c877bb4de4121675ec8c1318a2500a7 | |
| ToppCell | C_00|World / shred on cell type and cluster | 5.09e-04 | 179 | 39 | 3 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 181 | 39 | 3 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.26e-04 | 181 | 39 | 3 | 7fb3c1d29c542a3cea7fa654432d501d82df138f | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.52e-04 | 184 | 39 | 3 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.78e-04 | 187 | 39 | 3 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.78e-04 | 187 | 39 | 3 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.87e-04 | 188 | 39 | 3 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.87e-04 | 188 | 39 | 3 | 2513ca0efa73c09a3406b99e2876982d78b173d7 | |
| ToppCell | (1)_T_CD4_fh|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.15e-04 | 191 | 39 | 3 | 66ddff9a99092cb384b9fb2a3ba95ddbebed67cc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.15e-04 | 191 | 39 | 3 | 4a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6 | |
| ToppCell | ILEUM-inflamed-(1)_Tregs|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.24e-04 | 192 | 39 | 3 | 1fe3417dfd1cf1758fd82c9ac13dbd88bdf0b548 | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.34e-04 | 193 | 39 | 3 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.43e-04 | 194 | 39 | 3 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | T/NK_cells-NKT_cell|World / Lineage and Cell class | 6.43e-04 | 194 | 39 | 3 | 8e09989ec2d1bbfe70cb18321c2ae94e0d0d9f18 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD8_TEM|IIF / Disease, Lineage and Cell Type | 6.43e-04 | 194 | 39 | 3 | f4f7c85963ba52ee7ca2ef5657e60680fe6332fe | |
| ToppCell | BLOOD--(1)_MAIT-like_CD8_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.43e-04 | 194 | 39 | 3 | 0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.43e-04 | 194 | 39 | 3 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | control-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.53e-04 | 195 | 39 | 3 | 55b9052336cab3e769a126ecaeef267d8e7bcaa8 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.53e-04 | 195 | 39 | 3 | 90136f65e3e72cf2b2e0a13b48a7c9d60628b396 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.53e-04 | 195 | 39 | 3 | 83dadac78e0dea5cfded82bc67a8f67a2f268ace | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.53e-04 | 195 | 39 | 3 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.53e-04 | 195 | 39 | 3 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 196 | 39 | 3 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | Severe-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.63e-04 | 196 | 39 | 3 | ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-04 | 196 | 39 | 3 | d323f7dc41380446e5967c69832bea88351a9331 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-GC_B_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-04 | 196 | 39 | 3 | d08f6143d148a897efacc854e4306455a9a9868c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.63e-04 | 196 | 39 | 3 | c06caba0c91b8ee66f42bc43ec75eb2475f07056 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 196 | 39 | 3 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.63e-04 | 196 | 39 | 3 | 093fb240e72911dfd360aa6edf8ed2d611c78a1e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-04 | 196 | 39 | 3 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | droplet-Liver-LIVER-NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 196 | 39 | 3 | a3513c91afdc2d363e1c57071ae2399f9b7e6263 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 196 | 39 | 3 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | (1)_T_CD8_MAIT|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.63e-04 | 196 | 39 | 3 | 5fc99a8e3dde12fd0b0b2e0a2db48ac16b42739e | |
| ToppCell | tumor_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.63e-04 | 196 | 39 | 3 | 7aa6778b78a8549dd4d0a5278ef8017334b00c38 | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.63e-04 | 196 | 39 | 3 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.63e-04 | 196 | 39 | 3 | 17f17edadafdad9f24e88d708d7e1c765503131c | |
| ToppCell | droplet-Liver-LIVER-NPC-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 196 | 39 | 3 | 0dfa2dc1ec527d40005614c00ed0e5f3a566c2e2 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.73e-04 | 197 | 39 | 3 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, condition lineage and cell class | 6.73e-04 | 197 | 39 | 3 | 8f35f9741086a38f0e594dce0547b575946f52bb | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 197 | 39 | 3 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.73e-04 | 197 | 39 | 3 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | Severe-Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.73e-04 | 197 | 39 | 3 | 1089aa7991812378668d0f3d57f8000e6245a713 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 197 | 39 | 3 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.73e-04 | 197 | 39 | 3 | a4ecac6ee8a0d4d85319104c179ec7711a3efb51 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.73e-04 | 197 | 39 | 3 | 653f5cfc44bc3b9218fa187df3d1d828070c2d44 | |
| ToppCell | (2)_NK/T-(22)_CD8+_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 6.73e-04 | 197 | 39 | 3 | 20dad8e4ed36a0185e231ddcb327725d2b2005e0 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 6.83e-04 | 198 | 39 | 3 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Transverse-T_cell-Th17|T_cell / Region, Cell class and subclass | 6.83e-04 | 198 | 39 | 3 | 918068ffd682c896c11d576072bde270630539d9 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 6.83e-04 | 198 | 39 | 3 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.83e-04 | 198 | 39 | 3 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.83e-04 | 198 | 39 | 3 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.83e-04 | 198 | 39 | 3 | 629a1229759f3088cafb36f27a3d19d7249aab3a | |
| ToppCell | (1)_T_cell-(13)_Th17|(1)_T_cell / shred on Cell_type and subtype | 6.83e-04 | 198 | 39 | 3 | a3ac65295da7baed447786a302b01db1cc824db2 | |
| ToppCell | Caecum-T_cell-Th17|T_cell / Region, Cell class and subclass | 6.83e-04 | 198 | 39 | 3 | c675878bec307c10326cb85fd398b30029d73522 | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.83e-04 | 198 | 39 | 3 | 2cd13418396ab2c53b1be96e7795841c2482bfca | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.83e-04 | 198 | 39 | 3 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | control-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.83e-04 | 198 | 39 | 3 | 13955a4026c97e11d94973ac87bf018f64a2616c | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_Tem|Bac-SEP / Disease, condition lineage and cell class | 6.83e-04 | 198 | 39 | 3 | 292b26f316f016b50d07689f84772eec46060251 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.83e-04 | 198 | 39 | 3 | d51b255f8d5069232031d4825e0707fddf67d0a2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-04 | 199 | 39 | 3 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 6.93e-04 | 199 | 39 | 3 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|myeloid / Lineage, cell class and subclass | 6.93e-04 | 199 | 39 | 3 | 1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5 | |
| ToppCell | COVID-19_Severe-PLT_5|World / Disease Group and Platelet Clusters | 6.93e-04 | 199 | 39 | 3 | 937e4028f896bc6b751182517611825d6716c682 | |
| ToppCell | Sigmoid-(2)_B_cell-(20)_B_cell_IgA_Plasma|Sigmoid / shred on region, Cell_type, and subtype | 6.93e-04 | 199 | 39 | 3 | f3c583f8521f63834d1afbf8b07940fee7712f9a | |
| ToppCell | Sigmoid-T_cell-Th17|T_cell / Region, Cell class and subclass | 6.93e-04 | 199 | 39 | 3 | 622f2ae4b1850b25f723a0385da49147dfec8285 | |
| ToppCell | COVID-19_Severe-PLT_5|COVID-19_Severe / Disease Group and Platelet Clusters | 6.93e-04 | 199 | 39 | 3 | 93e814f45b220687007c75f20ec1ea25234f7d65 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-04 | 199 | 39 | 3 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD4+_Tem|IIF / Disease, condition lineage and cell class | 6.93e-04 | 199 | 39 | 3 | a876d53a9cc5d1584bed5ff679be8f5273daad37 | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_Tem|ICU-NoSEP / Disease, condition lineage and cell class | 6.93e-04 | 199 | 39 | 3 | 3382dfd446e362c94d8d92a3d78c3d0022cbe69c | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-04 | 199 | 39 | 3 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | (22)_CD8+_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 6.93e-04 | 199 | 39 | 3 | e1261507f0adade3ba534d5b465c9c559fc3aed0 | |
| ToppCell | myeloid-Dendritic_cell|myeloid / Lineage, cell class and subclass | 6.93e-04 | 199 | 39 | 3 | b81c0a40481f1006ac4aa8759af95448cb5fc2e6 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.93e-04 | 199 | 39 | 3 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | Transverse-B_cell-B_cell_IgA_Plasma|Transverse / Region, Cell class and subclass | 6.93e-04 | 199 | 39 | 3 | ea65cadaf464ff4c1040fceb5f3724706f8447c1 | |
| ToppCell | Transverse-T_cell-Th17|Transverse / Region, Cell class and subclass | 6.93e-04 | 199 | 39 | 3 | 640989e048b08d66c5020e032a61ef05f3831034 | |
| Disease | Paroxysmal atrial fibrillation | 1.07e-03 | 156 | 38 | 3 | C0235480 | |
| Disease | familial atrial fibrillation | 1.07e-03 | 156 | 38 | 3 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.07e-03 | 156 | 38 | 3 | C2585653 | |
| Disease | Atrial Fibrillation | 1.15e-03 | 160 | 38 | 3 | C0004238 | |
| Disease | Moyamoya disease | 1.22e-03 | 40 | 38 | 2 | MONDO_0016820 | |
| Disease | birth weight, parental genotype effect measurement | 1.93e-03 | 192 | 38 | 3 | EFO_0004344, EFO_0005939 | |
| Disease | Necrosis | 2.30e-03 | 55 | 38 | 2 | C0027540 | |
| Disease | platelet component distribution width | 2.70e-03 | 755 | 38 | 5 | EFO_0007984 | |
| Disease | Brain Ischemia | 2.73e-03 | 60 | 38 | 2 | C0007786 | |
| Disease | Cerebral Ischemia | 2.73e-03 | 60 | 38 | 2 | C0917798 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGSPIMEEKRDDKSW | 806 | Q4VCS5 | |
| EMIPLDWEKGKLEGA | 1151 | Q12802 | |
| DGKMDKEETKDWILP | 246 | O43852 | |
| MGDEKDSWKVKTLDE | 1 | P21127 | |
| KEEGPKEMTLDEWKA | 281 | Q8NC51 | |
| EMDKWKGIEPGEKCA | 266 | Q9H4D5 | |
| YEKGRKMDWKVPEPE | 1171 | Q504Q3 | |
| KWDELKEAGVSDMKL | 431 | O00592 | |
| KSPKEELLKMWGEEL | 411 | P42898 | |
| GEWFKEGMKLEAIDP | 381 | Q05BQ5 | |
| EKMPGKSEIEDVTAW | 1621 | Q6PRD1 | |
| DGIEPMWEDEKNKRG | 96 | P06730 | |
| KWVPGLKESAEEMVK | 606 | Q9H501 | |
| PTMEEGNIVKWLKKE | 66 | O00330 | |
| WKPGKMEDDIDKIKP | 331 | O75530 | |
| WERDGMLKEKTGPKI | 841 | Q7L590 | |
| KMNGKVWDLFPEADK | 761 | B5ME19 | |
| MGDDSEWLKLPVDQK | 1 | Q14008 | |
| KGKMWEEAIALGKEL | 1286 | Q14185 | |
| DGKWEVEEMKESKLP | 101 | P27824 | |
| MGDEKDSWKVKTLDE | 1 | Q9UQ88 | |
| ESGKKPSWMEEEDLS | 31 | Q13495 | |
| MSWDKGERTEPLEKT | 621 | P42701 | |
| EMKQGKKWSLEDDDD | 191 | Q7L014 | |
| MPDDEGEGELCWKKV | 356 | Q8TB52 | |
| FKEGIKPMWEDDANK | 116 | O60573 | |
| KEGEQKGEEMEKLTW | 436 | Q8WUM9 | |
| DSLDKSGLFPEWKKM | 216 | Q96C24 | |
| DKWKPPQGTDSIKME | 31 | Q9UHX1 | |
| NQEEKWKGMEEPGEK | 1961 | Q8WXH0 | |
| LLGKWKPMDVEDSLE | 351 | Q8NEB9 | |
| LGKIWKLADIDKDGM | 481 | Q9NZN3 | |
| ELSWLDDLMPESKKK | 1031 | Q6U841 | |
| NWEDAEMKLKGKPDG | 406 | O14512 | |
| EGTKWGEEALKMDLD | 651 | Q8NAP3 | |
| RGGKAEDKEWMPVTK | 51 | P15880 | |
| SLLEQGKEPWMVKKE | 56 | Q96ND8 | |
| SGQEMKVLPEGKDWK | 531 | B1ANS9 | |
| SQLEKGEEPWMAEKE | 126 | Q49AA0 |